Etiopathogenesis of primary biliary cirrhosis

Ana Lleo, Pietro Invernizzi, Ian R. Mackay, Harry Prince, Ren Qian Zhong, M. Eric Gershwin

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Primary biliary cirrhosis (PBC) is an autoimmune disease of the liver characterized by progressive bile duct destruction eventually leading to cirrhosis and liver failure. The serological hallmark of the disease is the presence of circulating antimitochondrial antibodies (AMA). These reflect the presence of autoreactive T and B cells to the culprit antigens, the E2 subunits of mitochondrial 2-oxo-acid dehydrogenase enzymes, chiefly pyruvate dehydrogenase (PDC-E2). The disease results from a combination of genetic and environmental risk factors. Genetic predisposition is indicated by the higher familial incidence of the disease particularly among siblings and the high concordance rate among monozygotic twins. Environmental triggering events appear crucial to disrupt a preexisting unstable immune tolerance of genetic origin allowing, after a long latency, the emergence of clinical disease. Initiating mimetopes of the vulnerable epitope of the PDC-E2 autoantigen can be derived from microbes that utilize the PDC enzyme or, alternatively, environmental xenobiotics/chemical compounds that modify the structure of native proteins to make them immunogenic. A further alternative as a source of antigen is PDC-E2 derived from apoptotic cells. In the effector phase the biliary ductular cell, by reason of its proclivity to express the antigen PDC-E2 in the course of apoptosis, undergoes a multilineage immune attack comprised of CD4+ and CD8+ T cells and antibody. In this article, we critically review the available evidence on etiopathogenesis of PBC and present interpretations of complex data, new developments and theories, and nominate directions for future research.

Original languageEnglish (US)
Pages (from-to)3328-3337
Number of pages10
JournalWorld Journal of Gastroenterology
Volume14
Issue number21
DOIs
StatePublished - 2008

Fingerprint

Biliary Liver Cirrhosis
Oxidoreductases
Keto Acids
T-Lymphocytes
Immune Tolerance
Monozygotic Twins
Antibodies
Liver Failure
Autoantigens
Xenobiotics
Enzymes
Genetic Predisposition to Disease
Bile Ducts
Pyruvic Acid
Autoimmune Diseases
Siblings
Epitopes
Fibrosis
B-Lymphocytes
Apoptosis

Keywords

  • 2-oxoacid dehydrogenase
  • Autoantibodies
  • Autoreactive T cells
  • Biliary epithelial cells
  • Primary biliary cirrhosis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Lleo, A., Invernizzi, P., Mackay, I. R., Prince, H., Zhong, R. Q., & Gershwin, M. E. (2008). Etiopathogenesis of primary biliary cirrhosis. World Journal of Gastroenterology, 14(21), 3328-3337. https://doi.org/10.3748/wjg.14.3328

Etiopathogenesis of primary biliary cirrhosis. / Lleo, Ana; Invernizzi, Pietro; Mackay, Ian R.; Prince, Harry; Zhong, Ren Qian; Gershwin, M. Eric.

In: World Journal of Gastroenterology, Vol. 14, No. 21, 2008, p. 3328-3337.

Research output: Contribution to journalArticle

Lleo, A, Invernizzi, P, Mackay, IR, Prince, H, Zhong, RQ & Gershwin, ME 2008, 'Etiopathogenesis of primary biliary cirrhosis', World Journal of Gastroenterology, vol. 14, no. 21, pp. 3328-3337. https://doi.org/10.3748/wjg.14.3328
Lleo, Ana ; Invernizzi, Pietro ; Mackay, Ian R. ; Prince, Harry ; Zhong, Ren Qian ; Gershwin, M. Eric. / Etiopathogenesis of primary biliary cirrhosis. In: World Journal of Gastroenterology. 2008 ; Vol. 14, No. 21. pp. 3328-3337.
@article{67becd63226f4728b9b521eb33862824,
title = "Etiopathogenesis of primary biliary cirrhosis",
abstract = "Primary biliary cirrhosis (PBC) is an autoimmune disease of the liver characterized by progressive bile duct destruction eventually leading to cirrhosis and liver failure. The serological hallmark of the disease is the presence of circulating antimitochondrial antibodies (AMA). These reflect the presence of autoreactive T and B cells to the culprit antigens, the E2 subunits of mitochondrial 2-oxo-acid dehydrogenase enzymes, chiefly pyruvate dehydrogenase (PDC-E2). The disease results from a combination of genetic and environmental risk factors. Genetic predisposition is indicated by the higher familial incidence of the disease particularly among siblings and the high concordance rate among monozygotic twins. Environmental triggering events appear crucial to disrupt a preexisting unstable immune tolerance of genetic origin allowing, after a long latency, the emergence of clinical disease. Initiating mimetopes of the vulnerable epitope of the PDC-E2 autoantigen can be derived from microbes that utilize the PDC enzyme or, alternatively, environmental xenobiotics/chemical compounds that modify the structure of native proteins to make them immunogenic. A further alternative as a source of antigen is PDC-E2 derived from apoptotic cells. In the effector phase the biliary ductular cell, by reason of its proclivity to express the antigen PDC-E2 in the course of apoptosis, undergoes a multilineage immune attack comprised of CD4+ and CD8+ T cells and antibody. In this article, we critically review the available evidence on etiopathogenesis of PBC and present interpretations of complex data, new developments and theories, and nominate directions for future research.",
keywords = "2-oxoacid dehydrogenase, Autoantibodies, Autoreactive T cells, Biliary epithelial cells, Primary biliary cirrhosis",
author = "Ana Lleo and Pietro Invernizzi and Mackay, {Ian R.} and Harry Prince and Zhong, {Ren Qian} and Gershwin, {M. Eric}",
year = "2008",
doi = "10.3748/wjg.14.3328",
language = "English (US)",
volume = "14",
pages = "3328--3337",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "21",

}

TY - JOUR

T1 - Etiopathogenesis of primary biliary cirrhosis

AU - Lleo, Ana

AU - Invernizzi, Pietro

AU - Mackay, Ian R.

AU - Prince, Harry

AU - Zhong, Ren Qian

AU - Gershwin, M. Eric

PY - 2008

Y1 - 2008

N2 - Primary biliary cirrhosis (PBC) is an autoimmune disease of the liver characterized by progressive bile duct destruction eventually leading to cirrhosis and liver failure. The serological hallmark of the disease is the presence of circulating antimitochondrial antibodies (AMA). These reflect the presence of autoreactive T and B cells to the culprit antigens, the E2 subunits of mitochondrial 2-oxo-acid dehydrogenase enzymes, chiefly pyruvate dehydrogenase (PDC-E2). The disease results from a combination of genetic and environmental risk factors. Genetic predisposition is indicated by the higher familial incidence of the disease particularly among siblings and the high concordance rate among monozygotic twins. Environmental triggering events appear crucial to disrupt a preexisting unstable immune tolerance of genetic origin allowing, after a long latency, the emergence of clinical disease. Initiating mimetopes of the vulnerable epitope of the PDC-E2 autoantigen can be derived from microbes that utilize the PDC enzyme or, alternatively, environmental xenobiotics/chemical compounds that modify the structure of native proteins to make them immunogenic. A further alternative as a source of antigen is PDC-E2 derived from apoptotic cells. In the effector phase the biliary ductular cell, by reason of its proclivity to express the antigen PDC-E2 in the course of apoptosis, undergoes a multilineage immune attack comprised of CD4+ and CD8+ T cells and antibody. In this article, we critically review the available evidence on etiopathogenesis of PBC and present interpretations of complex data, new developments and theories, and nominate directions for future research.

AB - Primary biliary cirrhosis (PBC) is an autoimmune disease of the liver characterized by progressive bile duct destruction eventually leading to cirrhosis and liver failure. The serological hallmark of the disease is the presence of circulating antimitochondrial antibodies (AMA). These reflect the presence of autoreactive T and B cells to the culprit antigens, the E2 subunits of mitochondrial 2-oxo-acid dehydrogenase enzymes, chiefly pyruvate dehydrogenase (PDC-E2). The disease results from a combination of genetic and environmental risk factors. Genetic predisposition is indicated by the higher familial incidence of the disease particularly among siblings and the high concordance rate among monozygotic twins. Environmental triggering events appear crucial to disrupt a preexisting unstable immune tolerance of genetic origin allowing, after a long latency, the emergence of clinical disease. Initiating mimetopes of the vulnerable epitope of the PDC-E2 autoantigen can be derived from microbes that utilize the PDC enzyme or, alternatively, environmental xenobiotics/chemical compounds that modify the structure of native proteins to make them immunogenic. A further alternative as a source of antigen is PDC-E2 derived from apoptotic cells. In the effector phase the biliary ductular cell, by reason of its proclivity to express the antigen PDC-E2 in the course of apoptosis, undergoes a multilineage immune attack comprised of CD4+ and CD8+ T cells and antibody. In this article, we critically review the available evidence on etiopathogenesis of PBC and present interpretations of complex data, new developments and theories, and nominate directions for future research.

KW - 2-oxoacid dehydrogenase

KW - Autoantibodies

KW - Autoreactive T cells

KW - Biliary epithelial cells

KW - Primary biliary cirrhosis

UR - http://www.scopus.com/inward/record.url?scp=54349090111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54349090111&partnerID=8YFLogxK

U2 - 10.3748/wjg.14.3328

DO - 10.3748/wjg.14.3328

M3 - Article

C2 - 18528930

AN - SCOPUS:54349090111

VL - 14

SP - 3328

EP - 3337

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 21

ER -